-+ 0.00%
-+ 0.00%
-+ 0.00%

ROUGETX LAUNCHES WITH $58 MILLION SERIES A FINANCING TO ADVANCE FIRST-IN-CLASS TREATMENT FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA

Reuters·10/06/2026 07:02:04